Generic versus Trade Name (Brand) Drugs
Site Navigation
Questions
Additional Site Information
Generic medicines that You buy online are exact replicas of trade-name drugs (medications) each one having the same dosage, use, positive effects, negative side effects, the route of administration, risks, safety, and strength as the original brand drug. Put simply, the drug pharmacological effects are precisely the same as those in the trade-name counterpart medication.
One such example of a generic drug, one used for treating impotence, is Sildenafil. An original brand name for sildenafil is Viagra. (Often one finds that Trade names are usually capitalized while the generic conterpart name may not be.) A generic drug, used in the treatment of male pattern baldness, is Finasteride whereas a brand name for the exact same drug is Propecia.
Quit a few buyers experience concern as a result of generic drugs frequently being substantially cheaper to buy online than the trade brand-name version of the exact same drug. Consumers thus speculate whether or not the distinguishing characteristics of the medication and effectiveness have been compromised to make the far cheaper drug equivalent. The U.S. FDA (American Food and Drug Administration) states that any generic drug must be certified as safe and effective as the original trade-brand-name drug.
In fact, the generic drug is only less expensive because the manufacturers of these generics did not incur the huge expense of development, research as well as start out marketing costs associated with bringing a new medication to the buyer. If a drug company delivers a new drug onto the consumer market, the company has incurred substantial expenses normaly on the research, development, marketing and the promotion of the drug. When a new patent for a drug is granted it provides the company that developed the drug security as well as the exclusive right to sell the drug whilst said patent is in effect.
Near the end of the drug patent period, the manufacturer may apply to the U.S. FDA for permission to produce and sell a generic version of the brand drug. Not having incurred the startup cost for the drug, these generic drug firms can easily afford to manufacture sell the generic medications far cheaper. If a number of generic medication companies commence production and selling of a particular copy of a drug, the competition amongst them heats up and can play a role in driving the price of the generic drug downwards.
Today there appears to be little truth in the stories doing the rounds that generic drugs are produced in sub-standard drug manufacturing plants or are that the generic is poorer in standard and quality versus the trade-brand-name drugs. The FDA enforces the same quality standards for all drug production plants, and a number of generic drug companies offer both own trade brand-name and generic drugs. Another point is that, the U.S. FDA calculates that some 52% of global generic drug production is done by trade-brand-name drug companies.
